Ladies and gentlemen, thank you for standing by, and welcome to the Lilly Q2 2025 Earnings Conference Call. [Operator ...

US tariffs on Indian exports and wage pressures could increase the stress on growth, thereby raising the chances for more ...

PITTSBURGH, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) today reported financial results for the second quarter ending June 30, 2025 and provided a business ...

Eli Lilly reports strong Q2 2025 growth, driven by Mounjaro & Zepbound. Highlights include increased guidance, pipeline updates, and key clinical milestones.

Funding of end-of-service and post-retirement benefits: Presentation by Ms. Karen Farkas, Controller and Director, Division of Financial and Administrative Management (DFAM), 51st meeting of the ...